Published July 14, 2024
| Version v1
Journal article
Open
PHF6 suppresses self-renewal of leukemic stem cells in AML
Creators
- 1. University of Pennsylvania
- 2. University of Chicago
Description
Acute myeloid leukemia is characterized by uncontrolled proliferation of self-renewing myeloid progenitors accompanied by a differentiation arrest. PHF6 is a chromatin-binding protein mutated in myeloid leukemias, and its isolated loss increases mouse HSC self-renewal without malignant transformation. We report here that Phf6 knockout increases the aggressiveness of Hoxa9-driven AML over serial transplantation, and increases the frequency of leukemia initiating cells. We define the in vivo hierarchy of Hoxa9-driven AML and identify a population that we term the "LIC-e" (leukemia initiating cells enriched) population. We find that Phf6 loss expands the LIC-e population and skews its transcriptome to a more stem-like state; concordant transcriptome shifts are also observed on PHF6 knockout in a human AML cell line and in PHF6 mutant patient samples from the BEAT AML dataset. We demonstrate that LIC-e accumulation in Phf6 knockout AML occurs not due to effects on cell cycle or apoptosis, but due to an increase in the fraction of its progeny that retain LIC-e identity. Our work indicates that Phf6 loss increases AML self-renewal through context-specific effects on leukemia stem cells.
Data availability
All generated datasets have been deposited to GEO: GSE270756.Files
PHF6-suppresses-self-renewal-of-leukemic-stem-cells-in-AML.pdf
Files
(16.7 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:dbf65b090071f46a181b3b8dc492070d |
5.8 MB | Preview Download |
|
md5:8d096ecd4887bab9f170c5b6a5efd96b
|
10.9 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1038/s41375-024-02340-5
- Other
- oai:uchicago.tind.io:12816
Funding
- National Institute of Health
- R01-HL155144
- American Cancer Society
- 129784-IRG-16-188-38-IRG
- American Society of Hematology
- Faculty Scholar Award
- University of Pennsylvania
- Covid-19 Research Disruption Mitigation Fund
- American Society of Hematology
- Restart Award
- American Society of Hematology
- Scholar Award
- National Institute of Diabetes and Digestive and Kidney Diseases
- Co-Operative Center for Excellence in Hematology (CCEH) grant
- Abramson Cancer Center, NCI
- P30 016520